135 related articles for article (PubMed ID: 35876545)
1. Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data.
Remy A; Tran TH; Dubois J; Gavra P; Lapointe C; Winikoff R; Facundo GB; Théorêt Y; Kleiber N
Pediatr Blood Cancer; 2022 Oct; 69(10):e29897. PubMed ID: 35876545
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy for capillary-venous malformations.
Zerbib L; Ladraa S; Fraissenon A; Bayard C; Firpion M; Venot Q; Protic S; Hoguin C; Thomas A; Fraitag S; Duong JP; Kaltenbach S; Balducci E; Lefevre C; Villarese P; Asnafi V; Broissand C; Goudin N; Nemazanyy I; Autret G; Tavitian B; Legendre C; Arzouk N; Minard-Colin V; Chopinet C; Dussiot M; Adams DM; Mirault T; Guibaud L; Isenring P; Canaud G
Signal Transduct Target Ther; 2024 Jun; 9(1):146. PubMed ID: 38880808
[TBL] [Abstract][Full Text] [Related]
3. New and Emerging Targeted Therapies for Vascular Malformations.
Van Damme A; Seront E; Dekeuleneer V; Boon LM; Vikkula M
Am J Clin Dermatol; 2020 Oct; 21(5):657-668. PubMed ID: 32557381
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects.
Boscolo E; Limaye N; Huang L; Kang KT; Soblet J; Uebelhoer M; Mendola A; Natynki M; Seront E; Dupont S; Hammer J; Legrand C; Brugnara C; Eklund L; Vikkula M; Bischoff J; Boon LM
J Clin Invest; 2015 Sep; 125(9):3491-504. PubMed ID: 26258417
[TBL] [Abstract][Full Text] [Related]
5. Effect of sirolimus on coagulopathy of slow-flow vascular malformations.
Mack JM; Verkamp B; Richter GT; Nicholas R; Stewart K; Crary SE
Pediatr Blood Cancer; 2019 Oct; 66(10):e27896. PubMed ID: 31250546
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
7. Activity of a TIE2 inhibitor (rebastinib) in a patient with a life-threatening cervicofacial venous malformation.
Triana P; Lopez-Gutierrez JC
Pediatr Blood Cancer; 2023 Aug; 70(8):e30404. PubMed ID: 37158500
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
[TBL] [Abstract][Full Text] [Related]
9. Extensive venous/lymphatic malformations causing life-threatening haematological complications.
Mazereeuw-Hautier J; Syed S; Leisner RI; Harper JI
Br J Dermatol; 2007 Sep; 157(3):558-63. PubMed ID: 17573883
[TBL] [Abstract][Full Text] [Related]
10. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.
Mazoyer E; Enjolras O; Bisdorff A; Perdu J; Wassef M; Drouet L
Arch Dermatol; 2008 Jul; 144(7):861-7. PubMed ID: 18645137
[TBL] [Abstract][Full Text] [Related]
11. Development of Molecular Therapies for Venous Malformations.
Kangas J; Nätynki M; Eklund L
Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():6-19. PubMed ID: 29668117
[TBL] [Abstract][Full Text] [Related]
12. Alpelisib administration reduced lymphatic malformations in a mouse model and in patients.
Delestre F; Venot Q; Bayard C; Fraissenon A; Ladraa S; Hoguin C; Chapelle C; Yamaguchi J; Cassaca R; Zerbib L; Magassa S; Morin G; Asnafi V; Villarese P; Kaltenbach S; Fraitag S; Duong JP; Broissand C; Boccara O; Soupre V; Bonnotte B; Chopinet C; Mirault T; Legendre C; Guibaud L; Canaud G
Sci Transl Med; 2021 Oct; 13(614):eabg0809. PubMed ID: 34613809
[TBL] [Abstract][Full Text] [Related]
13. A xenograft model for venous malformation.
Goines J; Li X; Cai Y; Mobberley-Schuman P; Metcalf M; Fishman SJ; Adams DM; Hammill AM; Boscolo E
Angiogenesis; 2018 Nov; 21(4):725-735. PubMed ID: 29786783
[TBL] [Abstract][Full Text] [Related]
14. MRI phenotypes of localized intravascular coagulopathy in venous malformations.
Koo KS; Dowd CF; Mathes EF; Rosbe KW; Hoffman WY; Frieden IJ; Hess CP
Pediatr Radiol; 2015 Oct; 45(11):1690-5. PubMed ID: 26143286
[TBL] [Abstract][Full Text] [Related]
15. Analysis and Treatment of Multiple Severe Venous Vascular Malformation Syndrome Combined with Coagulopathy.
Qiao JB; Li J; Zhang XF
Chin Med J (Engl); 2015 Sep; 128(18):2546-8. PubMed ID: 26365978
[No Abstract] [Full Text] [Related]
16. Dabigatran etexilate in the treatment of localized intravascular coagulopathy associated with venous malformations.
Binet Q; Lambert C; Hermans C
Thromb Res; 2018 Aug; 168():114-120. PubMed ID: 30064682
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban in the treatment of TEK-related venous malformation.
Oo HP; Pasricha SR; Thompson B; Winship I; Scardamaglia L
Australas J Dermatol; 2022 Aug; 63(3):e255-e258. PubMed ID: 35460567
[TBL] [Abstract][Full Text] [Related]
18. Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation.
Li X; Cai Y; Goines J; Pastura P; Brichta L; Lane A; Le Cras TD; Boscolo E
Arterioscler Thromb Vasc Biol; 2019 Mar; 39(3):496-512. PubMed ID: 30626204
[TBL] [Abstract][Full Text] [Related]
19. Venous malformations of the lower limb with severe localized intravascular coagulopathy treated with radiofrequency ablation and resection.
Xu Z; Yang Y; Ge C; Tai M; Chen T; Zhang Q; Li K; Yang X; Qin Z
J Thromb Thrombolysis; 2023 Jul; 56(1):202-206. PubMed ID: 37184627
[TBL] [Abstract][Full Text] [Related]
20. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations.
Geeurickx M; Labarque V
J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1321-1333. PubMed ID: 33737259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
